October 9, 2026
Healthleap, a startup whose AI reads hospital patient records to flag conditions doctors may have missed, has raised $38 million in seed and Series A funding, TechCrunch reported exclusively.
Why it matters: Hospital AI is one of the few places where the return on investment is measured in shorter stays and dollars — and Healthleap says its customers are seeing at least five times what they pay.
What happened
Healthleap disclosed two rounds at once: an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The company is not disclosing its valuation.
Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, Healthleap started as a clinical nutrition tool Jemima had built for dietitians. The company later pivoted to a broader platform aimed at spotting undiagnosed illnesses in admitted hospital patients — conditions like malnutrition and delirium that often go unnoticed early on. CEO Josiah Meyer said the funding will go toward engineering, product, sales, and customer success.
How the platform works
Healthleap plugs into a hospital’s electronic health record system and uses language models to read clinicians’ written notes — picking up affirmative or negated mentions of clinical concepts such as poor appetite, recent weight loss, muscle loss, or trouble swallowing — then combines that with structured data like lab reports and vital signs to surface patients who may need a closer look.
Each night it analyzes every adult inpatient’s record; each morning it writes a risk score into the care team’s existing workflow with a dashboard showing patient trends. The company stresses the software does not diagnose patients — it only highlights items for additional review.
Malnutrition was the starting point, which makes sense: research cited by TechCrunch suggests 20% to 50% of hospital inpatients are malnourished, and malnutrition is linked to longer stays, impaired wound healing, infections, and higher mortality. Healthleap has also built programs to identify aspiration pneumonia, pressure ulcers, and congestive heart failure readmission risk, which it says are undergoing further clinical validation.
Why it matters — the “everything AI, tested” take
Plenty of health-AI startups make accuracy claims that are hard to verify from the outside. Healthleap’s pitch is different: it sells on hard, hospital-finance-team-validated ROI. The company offers outcome-based pricing and says every customer so far has seen at least a 5x hard return, in some cases more than 20x annually. At the Hospital of the University of Pennsylvania, Healthleap says its malnutrition program produced $23.8 million in annualized financial impact — $6.3 million from additional reimbursement and $17.5 million from shorter hospital stays.
The customer list backs up the claim: the platform has grown from 3 hospital partners to more than 50 in the past year, including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. Revenue grew more than 10x over the same period, according to the company.
Healthleap plans to expand from a handful of conditions to more than 40 major health conditions and move beyond hospitals into outpatient and home care. If the ROI numbers hold at that scale, flagging missed diagnoses could become one of AI’s least controversial footholds in medicine — because nobody argues with an empty bed going home sooner.
Frequently asked questions
Does Healthleap diagnose patients?
No. The company says its software only flags patients for additional review by clinicians; it does not make diagnoses.
Which hospitals use Healthleap?
Healthleap says its platform is deployed in more than 50 hospitals, with customers including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare.
Who founded Healthleap?
Siblings Jemima and Josiah Meyer founded the company in South Africa in 2022. Josiah Meyer is CEO.
Sources: TechCrunch